Why You Shouldn’t Skip the Flu Vaccine

Translate to Spanish or other 102 languages!

If you haven’t gotten your flu vaccine yet, now is a good time to do so – especially as family and friends come together for the holidays. Image for illustration purposes
If you haven’t gotten your flu vaccine yet, now is a good time to do so – especially as family and friends come together for the holidays. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – It’s National Influenza Awareness Week.

If you haven’t gotten your flu vaccine yet, now is a good time to do so – especially as family and friends come together for the holidays.

“You may be surrounded by people who are older or younger or can’t receive the vaccines and are actually immunocompromised, so it’s really important to protect not only yourself but your loved ones,” explained Neha Vyas, MD, family medicine physician for Cleveland Clinic.

- Advertisement -

Dr. Vyas said the flu vaccine can also help reduce the severity of symptoms if you do end up getting sick.

According to the CDC, the vaccine is recommended for anyone six months and older.

Side effects are generally mild and short-lived, if you do experience any.

They may include soreness at the injection site, fever, fatigue, muscle aches and headache.

- Advertisement -

“In addition to immunizing yourself and your loved ones, it’s important that you make sure you cover your cough, or if you’re not feeling well, be sure to wear a mask,” advised Dr. Vyas. “It’s also important that you wash your hands before you touch your face or before you eat, and ensure that all high touch surfaces such as doorknobs, kitchen sinks, and faucets are cleaned regularly with a sanitizing or disinfecting wipe.”

Dr. Vyas said besides the flu vaccine, the public should also get vaccinated for COVID-19, pneumonia and RSV, if eligible.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -